SCHEMBL5897735

SCHEMBL5897735

O=C(O)CCc1cccc(/C(Nc2ccccc2)=C2/C(=O)Nc3cc(F)ccc32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.44
FFAR1 O14842 6/20 0.40
PPARG P37231 4/20 0.39
PPARA Q07869 2/20 0.39
NR1H4 Q96RI1 2/20 0.39
PPARD Q03181 1/20 0.39
ITGB3 P05106 1/20 0.38
ITGA2B P08514 1/20 0.38
HPGD P15428 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
RAB9A P51151 3/20 0.36
POLB P06746 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5897738 1.00 BACE1 (0.44) BACE1FFAR1PPARGPPARANR1H4
SCHEMBL228167 0.93 FFAR1 (0.41) BACE1FFAR1PPARGPPARANR1H4
SCHEMBL228166 0.93 FFAR1 (0.41) BACE1FFAR1PPARGPPARANR1H4
SCHEMBL224002 0.91 BACE1 (0.40) BACE1FFAR1PPARGRAB9AMEN1
SCHEMBL228486 0.90 FFAR1 (0.42) BACE1FFAR1PPARGITGB3ITGA2B
SCHEMBL226889 0.90 FFAR1 (0.40) BACE1FFAR1PPARGPPARANR1H4
SCHEMBL226888 0.90 FFAR1 (0.40) BACE1FFAR1PPARGPPARANR1H4
SCHEMBL228487 0.90 FFAR1 (0.42) BACE1FFAR1PPARGITGB3ITGA2B
SCHEMBL226986 0.90 BACE1 (0.47) BACE1FFAR1PPARGNR1H4MAOA
SCHEMBL226985 0.90 BACE1 (0.47) BACE1FFAR1PPARGNR1H4MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1523473-B1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA (DE) 2013-02-27 EP disclosed
US-20060148883-A1 Medicaments for the Treatment or Prevention of Fibrotic Diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148883-A1 Medicaments for the Treatment or Prevention of Fibrotic Diseases COL1A1, MMP1, FOXM1 BACE1 2383/4885FFAR1 1856/4885PPARG 433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.